Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1967 2
1968 1
1970 2
1971 2
1974 2
1978 1
1979 1
1983 1
1984 1
1989 1
1990 1
1992 2
1994 3
1995 8
1996 1
1997 2
1998 3
1999 8
2000 8
2001 14
2002 8
2004 2
2005 1
2007 4
2008 5
2009 7
2010 8
2011 5
2012 7
2013 7
2014 7
2015 11
2016 7
2017 5
2018 9
2019 6
2020 9
2021 9
2022 7
2023 4
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Results by year

Filters applied: . Clear all
Page 1
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.
Imel EA, Glorieux FH, Whyte MP, Munns CF, Ward LM, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Högler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Mao M, Chen CY, Skrinar A, San Martin J, Portale AA. Imel EA, et al. Among authors: muroya k. Lancet. 2019 Jun 15;393(10189):2416-2427. doi: 10.1016/S0140-6736(19)30654-3. Epub 2019 May 16. Lancet. 2019. PMID: 31104833 Free PMC article. Clinical Trial.
[Hypophosphatasia].
Muroya K, Ogata T. Muroya K, et al. Ryoikibetsu Shokogun Shirizu. 2001;(33):858-9. Ryoikibetsu Shokogun Shirizu. 2001. PMID: 11462724 Review. Japanese. No abstract available.
Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level.
Imel EA, Glorieux FH, Whyte MP, Portale AA, Munns CF, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Högler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Chen A, Roberts MS, Ward LM. Imel EA, et al. Among authors: muroya k. J Clin Endocrinol Metab. 2023 Oct 18;108(11):2990-2998. doi: 10.1210/clinem/dgad230. J Clin Endocrinol Metab. 2023. PMID: 37084401 Free PMC article.
Ruvalcaba syndrome revisited.
Adachi M, Muroya K, Asakura Y, Kurosawa K, Nishimura G, Narumi S, Hasegawa T. Adachi M, et al. Among authors: muroya k. Am J Med Genet A. 2010 Jul;152A(7):1854-7. doi: 10.1002/ajmg.a.33429. Am J Med Genet A. 2010. PMID: 20583188 No abstract available.
Droperidol lowers the shivering threshold in rabbits.
Ueda K, Ishiyama T, Wada K, Muroya K, Kotoda M, Matsukawa T. Ueda K, et al. Among authors: muroya k. J Anesth. 2023 Dec;37(6):835-840. doi: 10.1007/s00540-023-03240-1. Epub 2023 Aug 11. J Anesth. 2023. PMID: 37566231
47,XXX male: A clinical and molecular study.
Ogata T, Matsuo M, Muroya K, Koyama Y, Fukutani K. Ogata T, et al. Among authors: muroya k. Am J Med Genet. 2001 Feb 1;98(4):353-6. doi: 10.1002/1096-8628(20010201)98:4<353::aid-ajmg1110>3.0.co;2-d. Am J Med Genet. 2001. PMID: 11170081 Review.
Additional report on Moreno-Nishimura-Schmidt overgrowth syndrome.
Handa A, Muroya K, Ishii T, Nishimura G. Handa A, et al. Among authors: muroya k. Am J Med Genet A. 2017 Oct;173(10):2834-2837. doi: 10.1002/ajmg.a.38368. Epub 2017 Jul 25. Am J Med Genet A. 2017. PMID: 28742279 No abstract available.
Androgen receptor gene and male genital anomaly.
Sasagawa I, Suzuki Y, Muroya K, Ogata T. Sasagawa I, et al. Among authors: muroya k. Arch Androl. 2002 Nov-Dec;48(6):461-6. doi: 10.1080/0148501029009372. Arch Androl. 2002. PMID: 12425763 Review.
188 results